Parkview Home | |
102 County State Aid Highway 9, Belview, Minnesota 56214 | |
(507) 938-4151 | |
Name | Parkview Home |
---|---|
Location | 102 County State Aid Highway 9, Belview, Minnesota |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 30 |
Occupancy Rate | 67.33% |
Medicare ID (CCN) | 245475 |
Legal Business Name | Parkview Home |
Ownership Type | Government - City |
NPI Number | 1609873652 |
Organization Name | PARKVIEW HOME |
Address | 102 Csah 9, Belview, MN 56214 |
Phone Number | 507-938-4151 |
News Archive
Research released today in the American Journal of Public Health found evidence that the tobacco industry has manipulated menthol levels and created new cigarette brands with the intention of gaining market share among young adults and adolescents.
The American Association for the Advancement of Science (AAAS) has honored Mary Helen Immordino-Yang with the AAAS Early Career Award for Public Engagement with Science for her "sustained commitment and novel approach to integrating public engagement with science into her extensive research and scholarly activities and for using public interactions to inform her research."
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the companies have submitted their reply to a complete response letter issued last month by the U.S. Food and Drug Administration (FDA) after review of the New Drug Application (NDA) submission for BYDUREON™ (exenatide for extended-release injectable suspension).
A new report from the National Research Council recommends that government agencies enhance their efforts to incorporate genomic data into risk assessments of chemicals and medicines, and calls for a concerted effort to fully develop these methods' potential to protect public health.
Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases, today announced it has achieved 100% specificity (no reproducible false positive results) upon testing 19,000 blood donations for variant Creutzfeldt-Jakob Disease ("vCJD") with the EP-vCJD(TM) Blood Screening Assay at l'Etablissement Français du Sang de Pyrénées Méditerrannée ("EFS-PM") in Montpellier, France.
› Verified 4 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Research released today in the American Journal of Public Health found evidence that the tobacco industry has manipulated menthol levels and created new cigarette brands with the intention of gaining market share among young adults and adolescents.
The American Association for the Advancement of Science (AAAS) has honored Mary Helen Immordino-Yang with the AAAS Early Career Award for Public Engagement with Science for her "sustained commitment and novel approach to integrating public engagement with science into her extensive research and scholarly activities and for using public interactions to inform her research."
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the companies have submitted their reply to a complete response letter issued last month by the U.S. Food and Drug Administration (FDA) after review of the New Drug Application (NDA) submission for BYDUREON™ (exenatide for extended-release injectable suspension).
A new report from the National Research Council recommends that government agencies enhance their efforts to incorporate genomic data into risk assessments of chemicals and medicines, and calls for a concerted effort to fully develop these methods' potential to protect public health.
Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases, today announced it has achieved 100% specificity (no reproducible false positive results) upon testing 19,000 blood donations for variant Creutzfeldt-Jakob Disease ("vCJD") with the EP-vCJD(TM) Blood Screening Assay at l'Etablissement Français du Sang de Pyrénées Méditerrannée ("EFS-PM") in Montpellier, France.
› Verified 4 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 1 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 2.9 | 14.46 |
Percentage of long-stay residents who lose too much weight | 5.71 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 70 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 3.95 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 2.63 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.37 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 13.16 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 83.33 | 83.88 |